---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-012870"
form_type: "8-K"
ticker: "TRVI"
cik: "0001563880"
company_name: "Trevi Therapeutics, Inc."
filed_at: "2023-04-14T23:59:59+00:00"
generated_at: "2026-06-17T01:55:05.062719+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Trevi Therapeutics amends bylaws to update proxy rules and meeting procedures

## Summary
- Eliminated requirement for stockholder list to be available at meeting.
- Added provisions for adjourning meetings due to technical failure in remote communication.
- Enhanced disclosure requirements for stockholder nominations under universal proxy rules (Rule 14a-19).
- Company may disregard nominations if stockholders fail to comply with Rule 14a-19 solicitation requirements.

## SEC filing metadata
- accession: 0000950170-23-012870
- form_type: 8-K
- ticker: TRVI
- cik: 0001563880
- company_name: Trevi Therapeutics, Inc.
- filed_at: 2023-04-14T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1563880/000095017023012870/0000950170-23-012870-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1563880/000095017023012870/trvi-20230413.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-012870
- JSON: https://secwatch.observer/filing/0000950170-23-012870.json
- Plain text: https://secwatch.observer/filing/0000950170-23-012870.txt

## Key facts
- Governance Changes
  Trevi Therapeutics, Inc.: On April 13, 2023, the Board approved an amendment and restatement of the bylaws to eliminate the requirement to make the stockholder list available during meetings, address adjournment due to technical failures in remote meetings, and revise procedural mechanics and disclosure requirements in light (effective 2023-04-13).
  - Change: bylaw amendment
  - Effective: 2023-04-13
  source text: On April 13, 2023, the Board of Directors of Trevi Therapeutics, Inc. (the “Company”) approved an amendment and restatement of the Company’s amended and restated bylaws (as so amended and restated, the “Amended and Restated Bylaws”), effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1563880/000095017023012870/0000950170-23-012870-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.